{
  "main_header": {
    "sid": 233635,
    "name": "Johnson Pharma",
    "stock_name": "Johnson Pharma",
    "full_name": "Johnson Pharmacare Ltd",
    "name_url": "stocks-analysis/johnson-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.51",
    "chg": -0.01,
    "chgp": "-1.92%",
    "dir": -1,
    "prev_price": "0.52",
    "mcapval": "29.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532154,
    "symbol": "",
    "ind_name": "Diversified Commercial Services",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE560F01022",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "5.46 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/johnson-pharma-233635-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 78,
    "sid": "233635",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/johnson-pharmacare-233635"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "21-Mar-2026",
      "details": "Intimation of Closure of Trading Window as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 for the Quarter and Year Ended on 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "17-Feb-2026",
      "details": "Disclosure as per Regulation 30 of SEBI LODR Regualtion 2015 for the appointment of Additional Non- Executive & Independent Director.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Revised Outcome Of Meeting Of Board Of Directors Held On Friday 13Th February 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015(SEBI LODR Regulation).",
      "datetime": "17-Feb-2026",
      "details": "Revised outcome of Meeting of Board of Directors held on Friday 13th Feburay 2026 at Pursuant to Regulation 30 of SEBI LODR Regulation 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> stock split, ex-date: 05 Jan 22",
          "dt": "2022-01-05",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 07 Apr 22",
          "dt": "2022-04-07",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News